Patents by Inventor Juntian Zhang

Juntian Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250064991
    Abstract: Compounds capable of binding to granzyme B and comprising a radioactive moiety, for examples, compounds of Formula (I), and pharmaceutical compositions comprising such. Also provided herein are uses of the compounds and pharmaceutical composition in cancer treatment and/or imaging.
    Type: Application
    Filed: June 7, 2024
    Publication date: February 27, 2025
    Applicant: CytoSite Biopharma Inc.
    Inventors: Geoffrey Malcolm BILCER, Hui XIONG, Carey HORCHLER, Mark A. CASTANARES, Brian LIEBERMAN, Juntian ZHANG, Francisco A. VALENZUELA
  • Publication number: 20250032650
    Abstract: Compounds capable of binding to granzyme B and comprising a radioactive moiety, for examples, compounds of Formula (I), and pharmaceutical compositions comprising such. Also provided herein are uses of the compounds and pharmaceutical composition in cancer treatment, and kits and methods for cancer therapy.
    Type: Application
    Filed: June 7, 2024
    Publication date: January 30, 2025
    Applicant: CytoSite BioPharma Inc.
    Inventors: Geoffrey Malcolm BILCER, Hui XIONG, Carey HORCHLER, Mark A. CASTANARES, Brian LIEBERMAN, Wei ZHANG, Xuan HUANG, Juntian ZHANG
  • Publication number: 20250021014
    Abstract: The present application discloses a scanning electron microscopic direct-write lithography system based on a compliant nano servo motion system, which includes an electron chamber, an ion chamber, a specimen chamber and a control system, wherein the electron chamber includes an electron chamber housing, an electron gun, an anode, an electron beam blanker, an electromagnetic lens and an electron beam deflection coil, the ion chamber includes an ion chamber housing, an ion source, an ion beam-scanning deflection electrode and the like, the specimen chamber includes a specimen chamber housing, a secondary electron detector, a nanoscale-precision compliant servo motion stage system and the like; control system includes a computer, an electron beam scanning controller, an ion beam scanning controller and the like.
    Type: Application
    Filed: September 13, 2024
    Publication date: January 16, 2025
    Applicant: Tsinghua University
    Inventors: Zhen ZHANG, Yijie LIU, Juntian QU
  • Patent number: 8765695
    Abstract: The present invention relates to use of an active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt for preparing a medicament and a health care product for improving sexual function of male mammals, and for providing the effect of spermatogenesis. The present invention further relates to a pharmaceutical composition for improving sexual function of male mammals, and/or for providing the effect of spermatogenesis, which comprises at least one active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt, and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: December 25, 2007
    Date of Patent: July 1, 2014
    Assignees: Jecui Health Industry Corp. Ltd., Institute of Materia Medica, Chinese Academy of Medical Sciences
    Inventors: Juntian Zhang, Shifeng Chu
  • Publication number: 20110034403
    Abstract: The present invention relates to use of an active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt for preparing a medicament and a health care product for improving sexual function of male mammals, and for providing the effect of spermatogenesis. The present invention further relates to a pharmaceutical composition for improving sexual function of male mammals, and/or for providing the effect of spermatogenesis, which comprises at least one active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt, and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: December 25, 2007
    Publication date: February 10, 2011
    Applicant: INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Juntian Zhang, Shifeng Chu
  • Publication number: 20060167276
    Abstract: The present invention relates to stereo isomers of C5-hydroxyl substituents, N-substituted derivatives of hydroxybenzyl, hydroxyl, phenyl substituted ?-lactams (clausenamide) and the preparation methods thereof, and pharmaceutical compositions containing the same and their uses for the preparation of medicaments as nootropic and anti-aging drugs.
    Type: Application
    Filed: December 31, 2003
    Publication date: July 27, 2006
    Inventors: Liang Huang, Juntian Zhang, Kemei Wu, Shiming Chen
  • Patent number: 6787564
    Abstract: The present invention relates to some new optically active clausenamide derivatives, process of the preparation thereof, a pharmaceutical composition containing the same and their medical use, particularly their use in the respects of hypoxia protective, nootropic and neurodegenerative disease such as cerebral ischemia, Alzheimer disease and vascular dementia.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: September 7, 2004
    Assignee: Institute of Materia Medica, Chinese Academy of Medical Sciences
    Inventors: Juntian Zhang, Liang Huang, Kemei Wu, Shiming Chen
  • Patent number: 6689808
    Abstract: The invention relates to compounds of formula (I): wherein R1 represents alkyl or ureido, R2 represents alkyl or hydrogen, or R1 and R2 together form a 5- or 6-membered ring, R3 represents CN, NO2, NRaR′a, NRaSO2R′a, NRaCZR5 or CZNRaR′a, R4 represents hydrogen or R3, and medicinal products containing the same which are useful in treating or preventing epilepsy and neurodegenerative diseases.
    Type: Grant
    Filed: December 26, 2002
    Date of Patent: February 10, 2004
    Assignee: Les Laboratoires Servier
    Inventors: Zongru Guo, Fengming Chu, Juntian Zhang, Guangzhong Yang, Bailing Xu, Xinyi Niu, Zhihong Ren, Pierre Lestage, Pierre Renard
  • Publication number: 20030220393
    Abstract: The invention relates to compounds of formula (I): wherein R1 represents an alkyl or ureido group, R2 represents an alkyl group or a hydrogen atom, or R1 and R2 together form a 5- or 6-membered ring, R3 represents a group CN, NO2, NRaR′a, NRaSO2,R′aCZR5 or CZNRaR′a, R4 represents a hydrogen atom or a group R3.
    Type: Application
    Filed: December 26, 2002
    Publication date: November 27, 2003
    Inventors: Zongru Guo, Fengming Chu, Juntian Zhang, Guangzhong Yang, Bailing Xu, Xinyi Niu, Zhihong Ren, Pierre Lestage, Pierre Renard
  • Publication number: 20030207935
    Abstract: The present invention relates to some new optically active clausenamide derivatives, process of the preparation thereof, a pharmaceutical composition containing the same and their medical use, particularly their use in the respects of hypoxia protective, nootropic and neurodegenerative disease such as cerebral ischemia, Alzheimer disease and vascular dementia.
    Type: Application
    Filed: March 26, 2002
    Publication date: November 6, 2003
    Applicant: INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Juntian Zhang, Liang Huang, Kemei Wu, Shiming Chen